Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001410578-23-000283
Filing Date
2023-03-17
Accepted
2023-03-17 15:56:52
Documents
86
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-K tmb-20221231x10k.htm   iXBRL 10-K 2227616
2 EX-31.1 tmb-20221231xex31d1.htm EX-31.1 15288
3 EX-32.1 tmb-20221231xex32d1.htm EX-32.1 7732
4 GRAPHIC tmb-20221231x10k001.jpg GRAPHIC 5726
5 GRAPHIC tmb-20221231x10k002.jpg GRAPHIC 5455
  Complete submission text file 0001410578-23-000283.txt   9500371

Data Files

Seq Description Document Type Size
6 EX-101.SCH tmb-20221231.xsd EX-101.SCH 76849
7 EX-101.CAL tmb-20221231_cal.xml EX-101.CAL 60073
8 EX-101.DEF tmb-20221231_def.xml EX-101.DEF 262753
9 EX-101.LAB tmb-20221231_lab.xml EX-101.LAB 508171
10 EX-101.PRE tmb-20221231_pre.xml EX-101.PRE 466519
80 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20221231x10k_htm.xml XML 1638278
Mailing Address 55 ADMINISTRATION ROAD, UNIT 13 VAUGHAN A6 L4K-4G9
Business Address 55 ADMINISTRATION ROAD, UNIT 13 VAUGHAN A6 L4K-4G9 905-541-3833
Target Group Inc. (Filer) CIK: 0001586554 (see all company filings)

EIN.: 463610035 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-55066 | Film No.: 23742369
SIC: 2833 Medicinal Chemicals & Botanical Products